WASHINGTON D.C.: The Food and Drug Administration (FDA) has approved the first app for iPhone and Android phones to deliver insulin doses for diabetes patients.
In a statement, Tandem Diabetes Care confirmed its “t:connect” mobile app, combined with its “t:slim X2” insulin pump, will allow insulin users to administer single doses of insulin directly through their smartphone.
The company said the feature is used for bolus insulin dosing, which, according to the nonprofit organization Beyond Type 1, is taken to prevent glucose spikes after meals.
In a statement, John Sheridan, president and CEO of Tandem Diabetes Care, said, “This FDA clearance further validates our commitment to innovation and the diabetes community by providing one of the most requested feature enhancements.”
The app will be available for free through a software update, but the company has not confirmed when it will be launched.
